High prevalence of metabolic syndrome in women newly diagnosed with endometrial cancer.

Nonetheless, just 9.2% (95% confidence intervals 7.3–11.2) of control women met the criteria for metabolic syndrome, more than five-fold fewer than our endometrial cancer patients, a comparison that was highly significant ( p < .0001), and mirrors previous work ( Rosato et al., 2011 ).

also in 132,142 other papers